The University of Maryland Medical Center's Mechanical Heart and Lung Support Program, also known as the Mechanical Circulatory Support Device Program (MCSD), has saved the lives of dozens of patients. By temporarily or permanently replacing hearts which have ceased to function effectively, the program has given new life -- new energy and new possibilities -- to people whose lives had been restricted by debilitating heart failure.
Mechanical circulatory support is just one of a spectrum of treatment options offered for heart patients at the University of Maryland. For appropriate patients, we may be able to offer new medical treatments or experimental drug trials (research), biventricular pacing, and transplantation as options.
UMMC's transplant program is unique in the region in having the full spectrum of surgical and non-surgical options available to our patients. This allows us to tailor our approach to each individual patient.
In addition, we are committed to developing promising new approaches to the care of end-stage heart and lung patients. In this way we are often able to offer patients who have no other good choices an opportunity to participate in clinical research trials that are not available elsewhere.
We have built a team of exceptionally well-trained, committed and gifted physicians, nurses, social workers, researchers and counselors whose special expertise guarantees that our patients receive the best treatment available. We are confident that as new advances are made -- and as we ourselves help to make them -- we will be able to help more people in the future.